Novo Holdings completes $16.5 billion takeover of Catalent
Novo Holdings has completed its $16.5 billion takeover of Catalent, the contract drug manufacturer announced on Wednesday, ...
manilatimes14m
DigiCert Releases First-of-Its-Kind Open-Source DCV Library to Elevate Industry Standards
The open-source DCV library builds on DigiCert's legacy of leadership in advancing transparency and best practices within the ...
Novo Holdings Completes Acquisition of Catalent
Catalent, Inc. ("Catalent"), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S ("Novo Holdings"), a global life sciences investment ...
The Herald-Times5h
Novo Holdings says its acquisition of Catalent will be complete 'in the coming days'
Indications are that Novo will be investing in both the plant and the community,” an Indiana University professor said.
NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark
Novo Nordisk is set to invest $1.2 billion for a new facility in Odense, Denmark, to produce various product types for rare ...